KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Accounts Payables (2016 - 2025)

Exact Sciences (EXAS) has disclosed Accounts Payables for 16 consecutive years, with $175.9 million as the latest value for Q4 2025.

  • Quarterly Accounts Payables rose 96.34% to $175.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $175.9 million through Dec 2025, up 96.34% year-over-year, with the annual reading at $175.9 million for FY2025, 96.34% up from the prior year.
  • Accounts Payables for Q4 2025 was $175.9 million at Exact Sciences, up from $129.4 million in the prior quarter.
  • The five-year high for Accounts Payables was $175.9 million in Q4 2025, with the low at $34.7 million in Q1 2021.
  • Average Accounts Payables over 5 years is $84.5 million, with a median of $75.0 million recorded in 2022.
  • The sharpest move saw Accounts Payables tumbled 30.23% in 2024, then surged 196.95% in 2025.
  • Over 5 years, Accounts Payables stood at $67.8 million in 2021, then rose by 10.45% to $74.9 million in 2022, then increased by 5.21% to $78.8 million in 2023, then rose by 13.65% to $89.6 million in 2024, then soared by 96.34% to $175.9 million in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $175.9 million, $129.4 million, and $157.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.